RNAZ
#4898
TransCode Therapeutics, Inc. - Common Stock
8.0 0 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.21%
Monthly Change
+55.64%
6 month change
-15.86%
Year Change
-15.86%
Previous Close
8.4 4
Open
8.3 5
Low
8.0 0
High
8.3 5
Volume
2
Financials
- Market Capitalization 7.6 M
- Employee 12
- Founded 2016
- CEO N/A
- Website www.transcodetherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00ZGYHV03
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.13
Price to sales ratio
-42.04
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4881 |  ELOX Eloxx Pharmaceuticals, Inc. | 11.60 USD | +5.94% | -5.77% | +16.00% | +16.00% | 7.99 M USD | ||
| 4888 |  MTVA MetaVia Inc. - Common Stock | 1.55 USD | -1.90% | +6.90% | -14.84% | +138.46% | 8.00 M USD | ||
| 4903 |  BOLT Bolt Biotherapeutics, Inc. - Common Stock | 4.09 USD | +0.99% | +6.79% | -14.79% | -32.84% | 7.86 M USD | ||
| 4905 |  PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.72 USD | +1.41% | -6.49% | +1.41% | -33.94% | 7.73 M USD |
Frequently asked questions about TransCode Therapeutics, Inc. - Common Stock
What is the TransCode Therapeutics, Inc. - Common Stock stock price today?
The current price of TransCode Therapeutics, Inc. - Common Stock (RNAZ) is 8. Over the past 24 hours, the stock has changed by -5.21%. Follow the RNAZ chart for real-time price dynamics.
What is the stock ticker of TransCode Therapeutics, Inc. - Common Stock?
TransCode Therapeutics, Inc. - Common Stock trades under the ticker RNAZ. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is TransCode Therapeutics, Inc. - Common Stock stock going up?
RNAZ has changed by +14.94% over the last week, +55.64% over the last month, and -15.86% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was TransCode Therapeutics, Inc. - Common Stock net income for the last quarter?
TransCode Therapeutics, Inc. - Common Stock reported net income of -17.79 M for the last quarter. The previous quarter showed -13.44 M, which means net income changed by -32.30%.
How many employees does TransCode Therapeutics, Inc. - Common Stock have?
As of the latest available data, TransCode Therapeutics, Inc. - Common Stock has 12 employees. Workforce size can provide additional context about the company's scale and operations.
What is TransCode Therapeutics, Inc. - Common Stock EBITDA?
TransCode Therapeutics, Inc. - Common Stock EBITDA is -17.75 M, and its EBITDA margin is 84.1 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy TransCode Therapeutics, Inc. - Common Stock stock?
You can buy TransCode Therapeutics, Inc. - Common Stock (RNAZ) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in TransCode Therapeutics, Inc. - Common Stock stock?
Investing in TransCode Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RNAZ chart and related analysis on metatrader.com as part of your research.